FLGT

Jul 30, 2026, 23:00 UTC

Fulgent Genetics, Inc. reported a quarterly loss of $0.58 per share for Q2 2026, missing the Zacks Consensus Estimate of a loss of $0.46 per share, compared to earnings of $0.07 per share a year ago.